Printer Friendly

A. L. LABORATORIES ANNOUNCES FDA APPROVAL OF CLOTRIMAZOLE VAGINAL CREAM

 FORT LEE, N.J., July 23 /PRNewswire/ -- A. L. Laboratories, Inc. (NYSE: BMD) today announced that NMC Laboratories, its U.S. pharmaceuticals subsidiary specializing in creams and ointments, has received approval from the Food and Drug Administration to manufacture and market Clotrimazole Vaginal Cream, USP 1 percent.
 Clotrimazole Cream is used in the treatment of vaginal yeast infections. NMC's product is the only generic equivalent to the branded product, Gyne-Lotrimin . NMC anticipates marketing Clotrimazole Cream beginning in the fourth quarter of 1993.
 A. L. Laboratories is a multinational manufacturer and marketer of specialized and value-added, branded pharmaceuticals and animal health micronutrients, with plant sites in Illinois, Maryland, New Jersey, New York, North Carolina, Washington state, Denmark and Indonesia.
 -0- 7/23/93
 /CONTACT: Iris Daniels of A. L. Laboratories, 201-947-7774, or Donna N. Stein of Morgen-Walke Associates, Inc., 212-850-5600, for A. L. Laboratories/
 (BMD)


CO: A. L. Laboratories, Inc. ST: New Jersey IN: MTC SU:

CK -- NY044 -- 5118 07/23/93 11:46 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 23, 1993
Words:164
Previous Article:THE MASSACHUSETTS HEALTH & EDUCATION TAX-EXEMPT TRUST IPO LISTS ON THE AMERICAN STOCK EXCHANGE
Next Article:DUFF & PHELPS RATES SUBSIDIARIES OF MANULIFE FINANCIAL
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters